PMV Pharmaceuticals (PMVP)
(Delayed Data from NSDQ)
$1.31 USD
+0.08 (6.50%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $1.30 -0.01 (-0.76%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Fundamental Charts
About Dividend Yield (TTM)
PMV Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PMVP 1.31 +0.08(6.50%)
Will PMVP be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PMVP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PMVP
Here's Why PMV Pharmaceuticals (PMVP) Looks Ripe for Bottom Fishing
PMVP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for PMVP
Is PMVP building bullish momentum? Crossed Above 200 Day Moving Average shows up after surging 6.5%
200 Day Moving Average Resistance appears for PMVP after 1.6% move
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
PMVP forms Stochastic Buy Signal on September 17
Orbimed Advisors LLC Adjusts Holdings in PMV Pharmaceuticals Inc